Reich Kristian 的 Form 4 申報
MoonLake Immunotherapeutics（MLTX），2024/2/16 申報
- 申報編號
- 0001213900-24-014996
- 申報時間
- 2024/2/16
- 交易日
- 2024/2/14-2/16
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $365.5 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Reich KristianCIK 0001920553 | 高階主管（科學長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/2/14 | Class A ordinary shares, par value $0.0001 per share | S賣出處分 | −10,000 | $62.42F2 | −$624,200 | 3,017,483 | 間接 | |
| 2024/2/14 | Class A ordinary shares, par value $0.0001 per share | S賣出處分 | −10,000 | $62.43F4 | −$624,300 | 130,071 | 直接 | |
| 2024/2/15 | Class A ordinary shares, par value $0.0001 per share | S賣出處分 | −10,000 | $60.17F5 | −$601,700 | 3,007,483 | 間接 | |
| 2024/2/15 | Class A ordinary shares, par value $0.0001 per share | S賣出處分 | −10,000 | $60.16F6 | −$601,600 | 120,071 | 直接 | |
| 2024/2/16 | Class A ordinary shares, par value $0.0001 per share | S賣出處分 | −10,000 | $60.15F7 | −$601,500 | 2,997,483 | 間接 | |
| 2024/2/16 | Class A ordinary shares, par value $0.0001 per share | S賣出處分 | −10,000 | $60.15F8 | −$601,500 | 110,071 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $61.82 to $63.01. Upon request by the staff of the U.S. Securities and Exchange Commission (the "Commission"), the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $61.82 to $63.01. Upon request by the staff of the Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $58.10 to $63.95. Upon request by the staff of the Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $58.18 to $63.95. Upon request by the staff of the Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $59.34 to $61.17. Upon request by the staff of the Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $59.34 to $61.17. Upon request by the staff of the Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。